Ichimura Y - Search Results

1

Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse model.

Higuchi T, Takagi K, Tochimoto A, Ichimura Y, Hirose H, Sawada T, Shibata N, Harigai M, Kawaguchi Y. Higuchi T, et al. Among authors: ichimura y. Sci Rep. 2023 Nov 8;13(1):19378. doi: 10.1038/s41598-023-46737-1. Sci Rep. 2023. PMID: 37938601 Free PMC article.

2

Capillary abnormalities observed by nailfold video-capillaroscopy in Japanese patients with systemic sclerosis.

Ichimura Y, Kawaguchi Y, Takagi K, Tochimoto A, Higuchi T, Kataoka S, Katsumata Y, Yamanaka H. Ichimura Y, et al. Mod Rheumatol. 2018 Nov;28(6):1066-1068. doi: 10.1080/14397595.2018.1430547. Epub 2018 Feb 8. Mod Rheumatol. 2018. PMID: 29357721 No abstract available.

3

Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment.

Higuchi T, Takagi K, Tochimoto A, Ichimura Y, Norose T, Katsumata Y, Masuda I, Yamanaka H, Morohoshi T, Kawaguchi Y. Higuchi T, et al. Among authors: ichimura y. Arthritis Res Ther. 2019 Apr 18;21(1):103. doi: 10.1186/s13075-019-1881-3. Arthritis Res Ther. 2019. PMID: 30999934 Free PMC article.

4

Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report.

Kishi T, Tani Y, Okiyama N, Mizuochi K, Ichimura Y, Harigai M, Nagata S, Miyamae T. Kishi T, et al. Among authors: ichimura y. Pediatr Rheumatol Online J. 2021 Mar 19;19(1):34. doi: 10.1186/s12969-021-00532-2. Pediatr Rheumatol Online J. 2021. PMID: 33740993 Free PMC article.

5

Association of elevated serum carbohydrate antigen 19-9 levels with extensive interstitial lung disease in patients with systemic sclerosis: A cross-sectional study.

Hirose H, Higuchi T, Takagi K, Tochimoto A, Ichimura Y, Katsumata Y, Harigai M, Kawaguchi Y. Hirose H, et al. Among authors: ichimura y. Int J Rheum Dis. 2024 Jan;27(1):e14978. doi: 10.1111/1756-185X.14978. Epub 2023 Nov 20. Int J Rheum Dis. 2024. PMID: 37983908

6

Evaluation of apremilast, an oral phosphodiesterase 4 inhibitor, for refractory cutaneous dermatomyositis: A phase 1b clinical trial.

Konishi R, Tanaka R, Inoue S, Ichimura Y, Nomura T, Okiyama N. Konishi R, et al. Among authors: ichimura y. J Dermatol. 2022 Jan;49(1):118-123. doi: 10.1111/1346-8138.16179. Epub 2021 Oct 3. J Dermatol. 2022. PMID: 34605053 Clinical Trial.

7

Murine models of idiopathic inflammatory myopathy.

Konishi R, Ichimura Y, Okiyama N. Konishi R, et al. Among authors: ichimura y. Immunol Med. 2023 Mar;46(1):9-14. doi: 10.1080/25785826.2022.2137968. Epub 2022 Oct 25. Immunol Med. 2023. PMID: 36282924 Review.

8

Blockade of CD122 on memory T cells in the skin suppresses sclerodermatous graft-versus-host disease.

Kubota N, Tanaka R, Ichimura Y, Konishi R, Tso JY, Tsurushita N, Nomura T, Okiyama N. Kubota N, et al. Among authors: ichimura y. J Dermatol Sci. 2023 Mar;109(3):127-135. doi: 10.1016/j.jdermsci.2023.03.003. Epub 2023 Mar 21. J Dermatol Sci. 2023. PMID: 36966029

9

Eribulin mesylate exerts antitumor effects via CD103.

Oya K, Nakamura Y, Watanabe R, Tanaka R, Ichimura Y, Kubota N, Matsumura Y, Tahara H, Okiyama N, Fujimoto M, Nomura T, Fujisawa Y. Oya K, et al. Among authors: ichimura y. Oncoimmunology. 2023 May 27;12(1):2218782. doi: 10.1080/2162402X.2023.2218782. eCollection 2023. Oncoimmunology. 2023. PMID: 37261089 Free PMC article.

10

Murine models of idiopathic inflammatory myopathies.

Okiyama N, Konishi R, Ichimura Y. Okiyama N, et al. Among authors: ichimura y. J Dermatol. 2024 Feb 6. doi: 10.1111/1346-8138.17142. Online ahead of print. J Dermatol. 2024. PMID: 38321631 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page